{'fraction_non_alphanumeric': 0.03424657534246575, 'fraction_numerical': 0.0136986301369863, 'mean_word_length': 5.8023255813953485, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Why do we say ‘neuroprotection’ in stroke when we mean ‘brain protection or cerebroprotection’?

We read with great interest the paper by Norrving et al., Action Plan for Stroke in Europe 2018–2030, recently published in European Stroke Journal. The authors includes two additional domains, on primary prevention and life after stroke, along with research and development priorities for translational stroke research. In this interesting manuscript, in the ‘Protective drugs for treatment and prevention’ section, specifically in ‘Neuroprotection’ subsection, the authors comment that